Member Portal    Donate Now!
 
  Clinical
ALS Trials
Trials
Browse Recruiting Trials
Search for a Trial
Clinical Trial News
Clinical Trials 101
Questions about Clinical Research?
Contact an ALS Trial Liaison


Call or email us with your questions
about clinical research

(877) 458-0631
alstrials@partners.org
 
 

March 12th Webinar: TDI 132 Information


Webinar: TDI 132 Information
March 12, 2012
3:00PM


This February, the ALS Therapy Development Institute announced that it plans to launch a clinical trial on a potential treatment for ALS called TDI 132 (aka fingolimod or Gilenya┬«).  The March webinar will focus on this effort.  We will provide an overview of the scientific rationale for this exciting planned trial as well as discuss the next steps forward.  Drs. Steve Perrin (ALS TDI) and James Berry (MGH/HMS) will be panelists for this discussion. 

Advanced registration is required.  View the archived webinar here.


 








 

For Patients & Families
Educational Webinars
Online NEALS Resources
Other Resources
Contact a Disease Specialist
Clinical Research Blog

For Researchers
Become a NEALS member
Post an ALS Clinical Trial
NEALS CRO Capabilities
Annual NEALS Meeting
NEALS Samples
NEALS Historical Data
ALS Trials
Browse Recruiting Trials
Search for a Trial
Clinical Trial News
Clinical Trials 101

Get Involved
Donate samples
Donate to our Clinical Research
About Us
Our Mission
Our Structure
Our Research
NEALS Members
Motor Neuron Disease
Connect with us: Member Portal       Donate Now!       Help       Sitemap       Contact Us